Jason Mehling, MD
Vascular & Interventional Radiology · Boulder, CONPI 1639127574
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for vascular & interventional radiology clinicians in CO, where the typical reported total is $3,523.
Across 141 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$620
- Merck$443
- Bayer$364
- Eisai Inc.$314
- Stryker$268
- Inari Medical, Inc.$266
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,003100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 20 | $620 |
| Merck | 18 | $443 |
| Bayer | 12 | $364 |
| Eisai Inc. | 11 | $314 |
| Stryker | 9 | $268 |
| Inari Medical, Inc. | 8 | $266 |
| E.r. Squibb & Sons, L.L.C. | 11 | $252 |
| Exelixis Inc. | 6 | $248 |
| Seagen Inc. | 6 | $163 |
| Penumbra, Inc. | 2 | $125 |
| Incyte Corporation | 4 | $85 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $80 |
| Karyopharm Therapeutics Inc. | 3 | $78 |
| Johnson & Johnson | 2 | $64 |
| Pfizer | 3 | $59 |
| AbbVie | 2 | $55 |
| Terumo Medical Corporation | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| GSK | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Mirati Therapeutics, Inc. | 1 | $30 |
| Geron Corporation | 1 | $30 |
| Bard Peripheral Vascular, Inc. | 1 | $28 |
| Beigene USA, Inc. | 1 | $28 |
| Sirtex Medical Inc | 1 | $27 |
| Z-medica, LLC | 1 | $26 |
| Sobi, Inc | 1 | $25 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Gilead | 1 | $25 |
| CTI Biopharma Corp. | 1 | $25 |
| Bristol Myers Squibb | 1 | $23 |
| Cordis US CORP. | 1 | $22 |
| Boston Scientific | 1 | $20 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $15 |
How this compares
$4,003 in reported general payments places this provider in the 50th percentile of 105 vascular & interventional radiology providers in Colorado.
See all vascular & interventional radiology providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Boulder
- Charles NuttingGreenwood Village$1.1M
- David KumpeAurora$844K
- Aaron KovaleskiLone Tree$429K
- Anthony BrownEnglewood$262K
- Premal TrivediAurora$206K
- Johnathan LindquistAurora$202K
- Elizabeth SpencerHighlands Ranch$189K
- Paul RochonThornton$145K
- Jason CarrollEnglewood$130K
- David JohnsonAurora$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.